Bohnen J M, Marshall J C, Fry D E, Johnson S B, Solomkin J S
Department of Surgery, University of Toronto, Ont.
Can J Surg. 1999 Apr;42(2):122-6.
In May 1997, a panel of surgeon-investigators met to discuss the clinical importance and research implications of controlling the source of abdominal infections. It was concluded that source control is critical to therapeutic success and that antimicrobial therapy and other adjunctive interventions will fail if the source of infection is not controlled by resection, exteriorization or other means. The panelists presented different definitions of source control, depending on the scientific purpose of the definition. All participants agreed that failure to consider the adequacy of source control of infection has limited the value of most clinical trials of therapeutic anti-infective agents. Besides recognizing source control as an essential goal of patient care, the panelists emphasized the need for further investigative work to define, record and stratify the adequacy of source control in clinical trials of therapeutic agents for abdominal infections.
1997年5月,一组外科医生兼研究人员召开会议,讨论控制腹部感染源的临床重要性及研究意义。得出的结论是,感染源控制对治疗成功至关重要,如果感染源未通过切除、外置或其他手段加以控制,抗菌治疗及其他辅助干预措施将会失败。根据定义的科学目的,小组成员提出了不同的感染源控制定义。所有参与者一致认为,未能考虑感染源控制的充分性限制了大多数治疗性抗感染药物临床试验的价值。除了将感染源控制视为患者护理的一项基本目标外,小组成员还强调,需要开展进一步的调查工作,以便在腹部感染治疗药物的临床试验中界定、记录和区分感染源控制的充分性。